Infusion-Related Reactions with Anti-CD20 Monoclonal Antibody Treatments in Multiple Sclerosis: Traditional Review

Abstract

Multiple sclerosis (MS) is chronic and autoimmune disease that is characterized by central nervous system damage. It is estimated that 2.8 million peo-ple have MS in the world and its incidence was found to be 2.1 per 100,000 people per year in a study involving 75 countries. 1 Although MS is a common dis-